Correction: Germ-line exon 21 EGFR V831H mutation in advanced NSCLC resistance to almonertinib: a case report

Authors

Institutions

Publication Details

Journal
Frontiers in Oncology
Published
2026-04-13
DOI
https://doi.org/10.3389/fonc.2026.1836262
Primary Topic
Lung Cancer Treatments and Mutations
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Correction: Germ-line exon 21 EGFR V831H mutation in advanced NSCLC resistance to almonertinib: a case report

Jian Lou, Daxia Cai, Yonghui Wang, Yanyan Zhu
Frontiers in Oncology
Lung Cancer Treatments and Mutations
article

Correction: Germ-line exon 21 EGFR V831H mutation in advanced NSCLC resistance to almonertinib: a case report

Jian Lou, Daxia Cai, Yonghui Wang, Yanyan Zhu
article en

Abstract

No abstract available for this paper.
Frontiers in OncologyVol. 16
Lishui Central Hospital (CN)
Good health and well-being
Openalex Percentile: Top 25%
Lung Cancer Treatments and Mutations
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.